Who makes [¹⁴C]-LY3372689?

[¹⁴C]-LY3372689 is developed by Eli Lilly and Company.

What development phase is [¹⁴C]-LY3372689 in?

[¹⁴C]-LY3372689 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[¹⁴C]-LY3372689

Eli Lilly and Company · Phase 1 active Small molecule

At a glance

Generic name	[¹⁴C]-LY3372689
Sponsor	Eli Lilly and Company
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[¹⁴C]-LY3372689 CI brief — competitive landscape report
[¹⁴C]-LY3372689 updates RSS · CI watch RSS
Eli Lilly and Company portfolio CI